Breaking News

Almac Expands Next-Gen Sequencing Capabilities with Illumina NovaSeq X Plus

Investment enhances Almac’s NGS portfolio of DNA sequencing service offerings.

Almac Diagnostic Services, a member of the Almac Group, expanded its next generation sequencing (NGS) capabilities for biopharma partners with the purchase and installation of the first Illumina NovaSeq X Plus instrument in Ireland. The investment enhances Almac’s NGS portfolio of DNA sequencing service offerings, including whole genome sequencing, whole exome sequencing, and a range of RNA sequencing service offerings for biomarker discovery projects. The Illumina NovaSeq X Plus enables l...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters